Dr. Maysa Abu-Khalaf, MD
Claim this profileThomas Jefferson University Hospital
Studies Breast Cancer
Studies Recurrence
11 reported clinical trials
24 drugs studied
Area of expertise
1Breast Cancer
Stage II
Stage III
HER2
2Recurrence
Stage II
Stage III
LH
Affiliated Hospitals
Clinical Trials Maysa Abu-Khalaf, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Fulvestrant + Binimetinib
for Breast Cancer
This trial is testing whether adding binimetinib to the usual treatment of fulvestrant can help patients with a specific type of advanced breast cancer. Fulvestrant works by blocking estrogen receptors on cancer cells, while binimetinib stops enzymes that help cancer grow. The goal is to see if this combination can better control the cancer compared to using fulvestrant alone.
Recruiting1 award Phase 219 criteria
More about Maysa Abu-Khalaf, MD
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Maysa Abu-Khalaf, MD has experience with
- Paclitaxel
- ELU001
- Olaparib
- Hyperthermia Treatment
- Short-Term Fasting
- Chemotherapy
Breakdown of trials Maysa Abu-Khalaf, MD has run
Breast Cancer
Recurrence
Tumors
Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maysa Abu-Khalaf, MD specialize in?
Maysa Abu-Khalaf, MD focuses on Breast Cancer and Recurrence. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage III.
Is Maysa Abu-Khalaf, MD currently recruiting for clinical trials?
Yes, Maysa Abu-Khalaf, MD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Maysa Abu-Khalaf, MD has studied deeply?
Yes, Maysa Abu-Khalaf, MD has studied treatments such as Paclitaxel, ELU001, Olaparib.
What is the best way to schedule an appointment with Maysa Abu-Khalaf, MD?
Apply for one of the trials that Maysa Abu-Khalaf, MD is conducting.
What is the office address of Maysa Abu-Khalaf, MD?
The office of Maysa Abu-Khalaf, MD is located at: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.